Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST-Modifier Gene Therapy for the Treatment of Stargardt Disease

Stock Information for Ocugen, Inc.

Loading

Please wait while we load your information from QuoteMedia.